NASDAQ · INO
Inovio Pharmaceuticals, Inc.
$0.77-$0.16 (-16.89%)
Inovio Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.63% below the high.
Loading market information…
XETRA · CNW.DE · EUR
Stock price
Quote as of Sep 30, 2022, 03:36 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
co.don AG’s quoted price sits in the lower half of its reported 52-week range, 89.57% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Established in 1993 and headquartered in Teltow, Germany, co.don AG operates as a global biopharmaceutical firm dedicated to the research, development, and marketing of cell-based pharmaceutical solutions. The company's core focus is on joint preservation and the regenerative repair of articular cartilage defects. Its offerings include Spherox, an advanced three-dimensional chondrocyte product specifically designed to address cartilage damage in adult knee joints. Additionally, co.don AG provides co.don chondrosphere, a therapy utilized for treating cartilage imperfections in younger patients across multiple joints, such as the hip, ankle, shoulder, elbow, and knees. These specialized treatments are primarily employed by orthopedic and trauma surgeons.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.77-$0.16 (-16.89%)
Inovio Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.63% below the high.
€0.09€0.00 (0.0%)
Clovis Oncology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.97% below the high.
€2.64-€0.16 (-5.71%)
ifa systems AG’s quoted price sits in the lower half of its reported 52-week range, 44.54% below the high.
€0.02€0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 88.28% below the high.
€0.12€0.00 (0.0%)
MagForce AG’s quoted price sits in the lower half of its reported 52-week range, 97.04% below the high.
€0.13-€0.05 (-27.64%)
Medigene AG’s quoted price sits in the lower half of its reported 52-week range, 96.79% below the high.
€0.00+€0.00 (+14.29%)
High Fusion Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
€0.05€0.00 (0.0%)
Paion AG’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
